methylprednisolone and melphalan

methylprednisolone has been researched along with melphalan in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (19.30)	18.7374
1990's	14 (24.56)	18.2507
2000's	19 (33.33)	29.6817
2010's	13 (22.81)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fritsch, H; Höltermann, F; Klug, S	1
de la Cierva, F; Gallego de la Fuente, MC; Medina Banegas, A; Osete Albaladejo, JM	1
Gore, ME; Malpas, JS; McElwain, TJ; Meldrum, M; Millar, BC	1
Bell, JB; Gore, ME; Maitland, JA; McElwain, TJ; Millar, BC; Montes, A; Treleaven, J	1
Bell, J; Clark, PI; Gore, ME; Judson, IR; Maitland, JA; Meldrum, M; Milan, S; Millar, B; Selby, PJ; Viner, C	1
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Kilpi, H; Palva, IP	1
Gore, ME; Judson, IR; Malpas, JS; McElwain, TJ; Meldrum, M; Viner, C	1
Gore, ME; Malpas, JS; McElwain, TJ; Meldrum, M; Millar, BC; Selby, PJ; Viner, C	1
Bell, JB; Gore, ME; Maitland, JA; McElwain, TJ; Millar, BC; Selby, PJ; Zuiable, A	1
Bury, J; Fillet, G; Salmon, J	1
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Apajalahti, J; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Palva, IP	1
Abramson, N; Ginsburg, AD; von Kapff, C	1
Alba, J; Arnalich, F; Barbado, FJ; García Puig, J; Gil, A; Muñoz, JA; Vázquez Rodríquez, JJ	1
Bosanquet, AG; Catovsky, D; Crotty, GM; McCann, SR; Mills, MJ	1
Chen, MG; Garton, JP; Gertz, MA; Greipp, PR; Inwards, DJ; Letendre, L; Litzow, MR; Pineda, AA; Solberg, LA; Witzig, TE	1
Holománová, D; Lipsic, T; Mikulecký, M; Mistrík, M; Sakalová, A; Steruská, M	1
Ala-Harja, K; Almqvist, A; Elonen, E; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Palva, IP	1
Amigo, ML; Caballero, MD; del Cañizo, C; García, R; Gonzalez, M; Hernández, JM; San Miguel, JF; Vazquez, L	1
Addessi, MA; Afeltra, A; Amoroso, A; Bonomo, L; Garzia, P; Pulsoni, A	1
Dreger, P; Glass, B; Kuse, R; Löffler, H; Schmitz, N; Schoch, R; Sonnen, R; Uharek, L; von Neuhoff, N	1
Kato, K; Kojima, S; Matsuyama, T	1
Usnarska-Zubkiewicz, L	1
Bhagwati, N; Horton, C; Kulkarni, S; Mainwaring, P; Mehta, J; Pandha, H; Powles, R; Singhal, S; Sirohi, B; Treleaven, J	1
Berger, M; Boiret, N; Deméocq, F; Halle, P; Kanold, J; Malpuech, G; Paillard, C; Rapatel, C; Yakouben, K	1
Child, JA; Davies, FE; Drayson, M; Evans, PA; Forsyth, PD; Morgan, GJ; Owen, RG; Pratt, G; Rawstron, AC; Richards, SJ; Selby, PJ; Smith, GM	1
Imai, K; Kawamura, T; Kondo, K; Sakurai, H; Sato, T; Takemori, N	1
Bock, PR; Chabronová, I; Dedík, L; Gazová, S; Hanisch, J; Holomanova, D; Hrubisko, M; Mistrík, M; Sakalová, A; Schiess, W	1
Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Millar, B; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J	1
Ashcroft, AJ; Child, JA; DasGupta, R; Davies, FE; Drayson, MT; Jack, AS; Morgan, GJ; Owen, RG; Patmore, R; Rawstron, AC	1
Mehta, AB; Shaw, B	1
Ausch, C; Buxhofer-Ausch, V; Habertheuer, KH; Hinterberger, W; Hinterberger-Fischer, M; Hruby, W; Kier, P; Ogris, E; Reiner-Concin, A; Ruckser, R; Schmid, I; Sebesta, C; Tatzreiter, G; Zelenka, P	1
Horton, C; Kulkarni, S; Mehta, J; Powles, R; Rudin, C; Saso, R; Singhal, S; Sirohi, B; Treleaven, J	1
De Raeve, H; Lambert, J; Rombouts, S; Schroyens, W; Van de Velde, A; Van de Voorde, K; Van Regenmortel, N	1
Cavanagh, J; Dyer, P; Horton, C; Kulkarni, S; Morgan, G; Oakervee, H; Powles, R; Rintala, T; Rudin, C; Sirohi, B; Treleaven, J	1
Jacobs, P; Mansvelt, E; Moodley, D; Ruff, P; Wood, L	1
Kuruvilla, J	1
Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T	1
Suzuki, K	1
Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG	1
Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K	1
Bajwa, RP; Rose, MJ; Woods, G	1
Belada, D; Berková, A; Bolomská, I; Burešová, L; Campr, V; Klener, P; Kozák, T; Kubáčková, K; Matuška, M; Pirnos, J; Přibylová, J; Pytlík, R; Sýkorová, A; Trněný, M; Vášová, I	1
Caballero, MD; Cabrero-Calvo, M; García-Sanz, R; Labrador, J; Mateos, MV; Pérez-López, E; Vázquez, L	1
Akhtar, S; Elhassan, TAM; Elshenawy, MA; Maghfoor, I; Shahzad Rauf, M	1

Reviews

7 review(s) available for methylprednisolone and melphalan

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Solitary rhinosinusal plasmacytoma. A review of its diagnosis and treatment]. Anales otorrinolaringologicos ibero-americanos, 1990, Volume: 17, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cobalt Radioisotopes; Combined Modality Therapy; Female; Humans; Maxillary Sinus Neoplasms; Melphalan; Methylprednisolone; Nose Neoplasms; Plasmacytoma; Radioisotope Teletherapy	1990
High-dose chemotherapy and autologous bone marrow transplantation for myeloma. European journal of haematology. Supplementum, 1989, Volume: 51 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Doxorubicin; Evaluation Studies as Topic; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Remission Induction; Transplantation, Autologous; Vincristine	1989
Systemic lupus erythematosus and multiple myeloma: a rare association. Seminars in arthritis and rheumatism, 1997, Volume: 26, Issue:6 Topics: Antineoplastic Agents; Cyclophosphamide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lupus Erythematosus, Systemic; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Recombinant Proteins; Recurrence	1997
Standard therapy of advanced Hodgkin lymphoma. Hematology. American Society of Hematology. Education Program, 2009 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2009
Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion. Clinical and experimental nephrology, 2012, Volume: 16, Issue:5 Topics: Aged; Amyloidosis; Bence Jones Protein; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulin Light-chain Amyloidosis; Kidney; Lenalidomide; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Renal Insufficiency; Thalidomide	2012
Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: report of a case and review of the literature. Pediatric transplantation, 2014, Volume: 18, Issue:1 Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Blood Platelets; Congenital Bone Marrow Failure Syndromes; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Melphalan; Methylprednisolone; Mucositis; Neutrophils; Thrombocytopenia; Transplantation Conditioning; Vidarabine	2014

Trials

11 trial(s) available for methylprednisolone and melphalan

Article	Year
Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1992, Volume: 48, Issue:1 Topics: Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Light Chains; Lomustine; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasm Staging; Recurrence; Treatment Outcome; Vincristine	1992
Treatment of multiple myeloma in old patients. Finnish Leukaemia Group. European journal of haematology, 1989, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Vincristine	1989
VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma. Bone marrow transplantation, 1989, Volume: 4 Suppl 4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Transplantation, Autologous; Vincristine	1989
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia Group. European journal of haematology, 1987, Volume: 38, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunoglobulins; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Vincristine	1987
Aggressive combination chemotherapy in multiple myeloma. A multicentre trial. Finnish Leukaemia Group. Scandinavian journal of haematology, 1985, Volume: 35, Issue:2 Topics: Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prognosis; Vincristine	1985
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta haematologica, 1995, Volume: 93, Issue:2-4 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fatal Outcome; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplastic Stem Cells; Palliative Care; Pilot Projects; Prednisolone; Prednisone; Remission Induction; Staining and Labeling; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vidarabine; Vinca Alkaloids; Vincristine	1995
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1993, Volume: 51, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine	1993
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure? British journal of cancer, 1998, Volume: 77, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methotrexate; Methylprednisolone; Middle Aged; Mitomycins; Prednisone; Prospective Studies; Treatment Outcome; Vincristine	1998
[Level of interleukin-6 (IL-6), soluble interleukin-6 receptors (sIL-6R) and tumor necrosis factor alpha (TNF-alpha) in untreated and progressing multiple myeloma]. Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 99, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Female; Humans; Interleukin-6; Kidney Failure, Chronic; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Survival Rate; Tumor Necrosis Factor-alpha; Vincristine	1998
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone marrow transplantation, 2000, Volume: 25, Issue:5 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Graft Survival; Heart Diseases; Hematopoietic Stem Cell Mobilization; Hospitalization; Humans; Interferons; Kidney Diseases; Male; Matched-Pair Analysis; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neutropenia; Neutrophils; Platelet Count; Recurrence; Sepsis; Survival Rate; Thrombocytopenia; Transplantation, Autologous; Vincristine	2000
Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'? Bone marrow transplantation, 2002, Volume: 30, Issue:8 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine	2002

Other Studies

39 other study(ies) available for methylprednisolone and melphalan

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
[IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia]. Deutsche medizinische Wochenschrift (1946), 1992, Jun-05, Volume: 117, Issue:23 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortic Valve Insufficiency; Drug Therapy, Combination; Female; Humans; Immunoglobulin lambda-Chains; Leukemia, Plasma Cell; Melphalan; Methylprednisolone; Mitral Valve Stenosis; Multiple Myeloma; Pericardial Effusion; Plasma Cells	1992
Intensive therapy for myeloma. Pathologie-biologie, 1990, Volume: 38, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Bone Marrow Transplantation; Humans; Melphalan; Methotrexate; Methylprednisolone; Multiple Myeloma; Prednisolone; Vincristine	1990
Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical response. British journal of cancer, 1990, Volume: 61, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Homeostasis; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Tumor Stem Cell Assay; Vincristine	1990
Intensive treatment of multiple myeloma and criteria for complete remission. Lancet (London, England), 1989, Oct-14, Volume: 2, Issue:8668 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Bone Marrow Transplantation; Doxorubicin; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Immunoglobulins; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Remission Induction; Time Factors; Vincristine	1989
Improved long-term survival in multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1989, Volume: 43, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Finland; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Prognosis; Remission Induction; Survival Analysis; Time Factors; Vincristine	1989
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma. British journal of haematology, 1989, Volume: 71, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Survival; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay; Verapamil; Vincristine	1989
[Monoclonal gammapathy of indeterminate origin and myeloma]. Revue medicale de Liege, 1988, Apr-15, Volume: 43, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Humans; Hypergammaglobulinemia; Interferon Type I; Melphalan; Methylprednisolone; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Prednisone; Vincristine	1988
The phagocytic plasma cells. The New England journal of medicine, 1970, Jul-30, Volume: 283, Issue:5 Topics: Aged; Bone Marrow; Bone Marrow Cells; Female; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Phagocytosis; Plasma Cells	1970
[Transformation of a rib plasmocytoma into an amyloid tumor (author's transl)]. Medicina clinica, 1981, Mar-25, Volume: 76, Issue:6 Topics: Aged; Amyloidosis; Clavicle; Female; Fractures, Spontaneous; Humans; Melphalan; Methylprednisolone; Nephrotic Syndrome; Plasmacytoma; Ribs	1981
Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. The American journal of the medical sciences, 1995, Volume: 309, Issue:3 Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Melphalan; Methylprednisolone; Middle Aged; Mucous Membrane; Multiple Myeloma; Pharyngitis; Recurrence; Whole-Body Irradiation	1995
Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma. Neoplasma, 1993, Volume: 40, Issue:6 Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; HLA-DR Antigens; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Isotypes; Immunophenotyping; Lomustine; Longitudinal Studies; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Plasma Cells; Prednisone; Prognosis; Regression Analysis; Survival Analysis; Vincristine	1993
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas. Annals of hematology, 1997, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methylprednisolone; Middle Aged; Myeloproliferative Disorders; Neutropenia; Salvage Therapy; Survival Rate; Time Factors	1997
Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Bone marrow transplantation, 1998, Volume: 22, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Female; Glucocorticoids; Graft vs Host Disease; Growth; Humans; Infant; Leukemia, Myeloid, Acute; Male; Melphalan; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous	1998
Two-step immunoablative treatment with autologous peripheral blood CD34(+) cell transplantation in an 8-year-old boy with autoimmune haemolytic anaemia. British journal of haematology, 2000, Volume: 110, Issue:4 Topics: Anemia, Hemolytic, Autoimmune; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cyclophosphamide; Cytarabine; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Melphalan; Methylprednisolone; Plasmapheresis; Podophyllotoxin; Prednisolone; Splenectomy; Stem Cells; Transplantation, Autologous; Treatment Outcome	2000
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma. British journal of haematology, 2001, Volume: 112, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Electrophoresis; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasm, Residual; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Vincristine	2001
Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment. American journal of hematology, 2001, Volume: 66, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Glucocorticoids; Humans; Immunoglobulin D; Immunoglobulin lambda-Chains; Interferons; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Nitrosourea Compounds; Prednisolone; Remission Induction; Vincristine	2001
Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer chemotherapy and pharmacology, 2001, Volume: 47 Suppl Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chymotrypsin; Cohort Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Combinations; Endopeptidases; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Papain; Prednisone; Proportional Hazards Models; Retrospective Studies; Survival Rate; Trypsin; Vincristine	2001
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Count; Combined Modality Therapy; Consensus Sequence; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Flow Cytometry; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin Heavy Chains; Life Tables; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Multivariate Analysis; Myeloma Proteins; Neoplasm, Residual; Neoplastic Stem Cells; Plasma Cells; Polymerase Chain Reaction; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine	2002
Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clinical and laboratory haematology, 2002, Volume: 24, Issue:6 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carbimazole; Cyclophosphamide; Doxorubicin; Graves Disease; Gynecomastia; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Ribs; Spinal Neoplasms; Thoracic Vertebrae; Transplantation Conditioning; Transplantation, Autologous; Vincristine	2002
A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma. European journal of haematology, 2004, Volume: 73, Issue:2 Topics: Anthracyclines; Female; Heart Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Interstitial; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2004
Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft. Hematology (Amsterdam, Netherlands), 2005, Volume: 10, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Vincristine	2005
Bortezomib-induced Sweet's syndrome. Haematologica, 2005, Volume: 90, Issue:12 Suppl Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Administration Schedule; Erectile Dysfunction; Humans; Immunosuppressive Agents; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Pain; Peripheral Nervous System Diseases; Prednisolone; Protease Inhibitors; Pyrazines; Recurrence; Sleep Initiation and Maintenance Disorders; Sweet Syndrome; Testicular Diseases	2005
Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lenograstim; Leukapheresis; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Remission Induction; Time Factors; Vincristine	2007
Amyloidosis: a changing clinical perspective. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2 Topics: Adult; Aged; Amyloidosis; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Colchicine; Diagnosis, Differential; Disease Management; Female; Humans; Immunotherapy; Lymphoproliferative Disorders; Male; Melphalan; Methylprednisolone; Middle Aged; Plasma Cells; Prednisone; Radioimmunotherapy; South Africa; Survival Rate	2007
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma]. Revue des maladies respiratoires, 2011, Volume: 28, Issue:7 Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult	2011
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. American journal of clinical oncology, 2015, Volume: 38, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult	2015
Myeloma presenting during pregnancy. Hematological oncology, 2014, Volume: 32, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous	2014
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial. Leukemia & lymphoma, 2015, Volume: 56, Issue:1 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Lymphoma, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Podophyllotoxin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult	2015
ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma. Annals of hematology, 2014, Volume: 93, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Evaluation; Etoposide; Febrile Neutropenia; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Melphalan; Methylprednisolone; Middle Aged; Radionuclide Imaging; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult	2014
Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant. Annals of hematology, 2018, Volume: 97, Issue:7 Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Kaplan-Meier Estimate; Male; Melphalan; Methylprednisolone; Middle Aged; Proportional Hazards Models; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Young Adult	2018